Understanding how natural rewards are influenced by brain opioid activity
Official title: Isolating the role of endogenous mu-opioid activity in the VTA during natural reward
Funded at University of Washington · NIH-10888174 · Data updated 2026-11-12
This study is looking at how certain brain cells that respond to natural rewards might be affected by opioids, which could help us understand why some people struggle with opioid use, especially during tough times like the COVID-19 pandemic.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | July 1, 2023 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $48,974 |
| NIH project number | 5F31DA059186-02 |
| Project ID | NIH-10888174 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals struggling with opioid use disorder or those interested in understanding the neurobiological factors influencing addiction.
✕Less likely to help
Patients who do not have a history of opioid use or are not affected by addiction-related issues may not benefit from this research.
What this research studies
This research investigates the role of endogenous mu-opioid activity in the Ventral Tegmental Area (VTA) of the brain and its impact on natural reward-seeking behaviors. By examining how specific neurons in the VTA interact with opioid receptors, the study aims to uncover the neuropharmacological mechanisms that contribute to opioid use disorder. The approach involves advanced techniques to observe neuronal activity and signaling pathways, providing insights into how these processes affect motivation and reward. This research is particularly relevant in the context of rising opioid use and overdose rates during the COVID-19 pandemic.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating opioid use disorder and improving addiction recovery.
How similar studies have gone: Previous research has shown promising results in understanding the neurobiology of addiction, suggesting that this approach could yield valuable insights.
Where this research is happening
-
University of Washington
Seattle, United States Active
Researchers
- Principal investigator: Zamorano, Catalina Alejandra — University of Washington
- Study coordinator: Zamorano, Catalina Alejandra
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.